CMI_LatestReportOrientedBlogs

Phosphoramidite Market The global phosphoramidite market is primarily driven by its wide application in synthetic biology. Phosphoramidites are primarily used in DNA synthesis for producing oligonucleotides and other synthetic DNA or RNA fragments through the phosphoramidite method. They are preferred as intermediates in solid phase oligonucleotide synthesis due to properties like ability to protect phosphorus moieties during oligonucleotide assembly procedures. Apart from DNA synthesis, phosphoramidites also find applications in polymerase chain reaction (PCR), targeted genome engineering methods like CRISPR and generation of DNA/RNA aptamers that are used for biosensing and targeted drug delivery applications. The Global phosphoramidite market is estimated to be valued at US$ 1,011.3 MN in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the global phosphoramidite market are Glen Research, ChemGenes Cor

Preclinical Imaging Market The global Preclinical Imaging market consists of various imaging modalities used for in-vivo imaging in small animals for research purposes in biological and preclinical studies. Preclinical Imaging allows researchers to non-invasively visualize and quantify biological processes at the molecular, cellular and anatomical level over time, in order to understand disease progression and evaluate the effectiveness of novel drug candidates or devices. Key Preclinical Imaging modalities include optical imaging, nuclear imaging, MRI, ultrasound, CT, and photoacoustic imaging. The need for Preclinical Imaging modalities has increased significantly owing to the growing research activities in drug discovery and development processes by pharmaceutical companies. Optical imaging dominates the market due to low cost and high-throughput capabilities for screening and studying molecular biological processes in living subjects. The Global Preclinical Imaging Market is es

Single Cell Genome Sequencing Market Single cell genome sequencing involves isolating single cells and analyzing the genome of each cell separately. It has gained prominence in recent years due to its ability to study cellular heterogeneity at an unprecedented resolution. Single cell sequencing helps to identify rare cell types and trace cell lineage decisions during development, disease onset and response to therapy. It has wide application in cancer research for understanding tumor evolution, detecting circulating tumor cells and deciphering intra-tumor heterogeneity. Other key applications of single cell sequencing include neurobiology, immunology and stem cell research. The Global Single Cell Genome Sequencing Market is estimated to be valued at US$ 2.63 Bn in 2024 and is expected to exhibit a CAGR of 3.9% over the forecast period from 2024 to 2030. Key Takeaways Key players operating in the single cell genome sequencing are Logitech International SA, Microsoft Corporation,

Phosphoramidite Market The global Phosphoramidite Market is primarily driven by its wide application in synthetic biology. Phosphoramidites are primarily used in DNA synthesis for producing oligonucleotides and other synthetic DNA or RNA fragments through the phosphoramidite method. They are preferred as intermediates in solid phase oligonucleotide synthesis due to properties like ability to protect phosphorus moieties during oligonucleotide assembly procedures. Apart from DNA synthesis, phosphoramidites also find applications in polymerase chain reaction (PCR), targeted genome engineering methods like CRISPR and generation of DNA/RNA aptamers that are used for biosensing and targeted drug delivery applications. The Global Phosphoramidite Market is estimated to be valued at US$ 1,011.3 MN in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the global Phosphoramidite Market are Glen Research, ChemGenes C

Bio-imaging Market Bio-imaging, also known as medical imaging, refers to technologies that are used to visualize parts of the body, assist in clinical diagnoses and guide patient management. It involves capturing images of the inside of the body for clinical analysis and medical intervention, with technologies including X-ray, MRI, ultrasound and PET scanning. Bio-imaging finds applications in various clinical specialties including cardiology, oncology, neurology and obstetrics. It helps detect and diagnose medical conditions at an early stage, enable non-invasive surgery with image guidance and allow timely monitoring of treatment responses. The growing geriatric population, rising cases of cancer and cardiovascular diseases and increasing awareness regarding benefits of early disease diagnosis are fueling demand for bio-imaging technologies globally. The Global bio-imaging Market is estimated to be valued at US$ 5.74 BN in 2024 and is expected to exhibit a CAGR of 15.% over the f

Genomics Market The genomics market has witnessed significant growth over the past few years owing to the growing adoption of genome sequencing technologies across various applications such as drug discovery and development, precision medicine, agriculture and animal research. Genomics plays a critical role in drug discovery and development by enabling target identification, biomarker identification and clinical trial enrichment. Advancements in next-generation genome sequencing technologies have enabled sequencing of the human genome at a much faster pace and lower costs. This has led to increased adoption of genomics tools and services in clinical settings for various applications such as cancer screening, prenatal testing and carrier screening. In addition, the use of genomics is increasingly adopted in agricultural applications for the development of higher yielding crop varieties and livestock breeding programs. The Global genomics market is estimated to be valued at US$ 53.23

Personalized Genomics Market   Personalized genomics involves genetic testing to understand specific genes and DNA variations associated with an individual's health and disease risks. Genetic testing enables early detection of genetic conditions and diseases, thereby improving patient outcomes. It aids in identifying customized drug prescriptions and treatment plans suitable for the individual's genetic make-up. The global Personalized Genomics Market is estimated to be valued at US$ 9.14 Bn in 2024 and is expected to exhibit a CAGR of 0.0% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The rapid adoption of genetic testing has accelerated market growth for personalized genomics. Genetic testing has gained immense popularity in recent years due to increasing awareness about its benefits. It enables people to understand their risks of developing certain diseases based on their DNA makeup and ta

Cancer Biologics Market Cancer Biologics are complex medical drugs that harness the power of living organisms and biological processes to treat and prevent cancer. These biologics utilize monoclonal antibodies, therapeutic vaccines, and other biological therapies to target specific antigens andmolecules involved in cancer growth and progression. With the rising global cancer burden and increasing preference for targeted and personalized treatment approaches, the demand for innovative Cancer Biologics has significantly grown in recent years. The global Cancer Biologics Market is estimated to be valued at US$ 174.8 billion in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024 - 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends driving the growth of the Cancer Biologics market is the rising incidence and prevalence of various cancer types globally. According to the World Health Organization (

Neutralizing Antibody Market Neutralizing antibodies are antibodies that are directed against specific antigens or pathogen epitopes and can neutralize pathogenic effects of macromolecules like proteins on cells or in extracellular space. Neutralizing antibodies help treat diseases like cancer, HIV, and infectious diseases by blocking the activity of targeted pathogens or antigens. The global Neutralizing Antibody Market is estimated to be valued at US$ 1.87 Bn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The growing prevalence of cancer and viral infections is the major factor augmenting the growth of the Neutralizing Antibody Market. As per WHO, cancer accounted for nearly 10 million deaths in 2020. Strong R&D efforts by key players to develop monoclonal neutralizing antibodies for treatment of various types of cancer is creating high demand for n

Genome Engineering Market Genome engineering technologies are used for modifying cellular DNA and RNA through the use of programmable nucleases. These technologies offer several advantages such as treatment of inherited genetic diseases, development of genetically modified crops with higher yields, and production of therapeutic proteins. Growing applications in the areas of healthcare and agriculture have increased the demand for genome engineering tools. The global Genome Engineering Market is estimated to be valued at US$ 6.87 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing demand for genome engineering in healthcare and agriculture is one of the major trends driving market growth. In the healthcare sector, genome engineering tools are being used for developing therapies for major diseases like cancer. CRISPR gene editing is being ext

Plasmid DNA Manufacturing Market Plasmid DNA is circular, double-stranded DNA molecule capable of autonomous replication distinct from chromosomal DNA. It is commonly used as a genetic vector to deliver therapeutic genes into cells and tissues for gene therapy and genetic vaccination. Plasmid DNA can be produced efficiently and rapidly at a large scale using microbial fermentation systems. With the rising use of plasmid DNA as a backbone for delivering gene sequences in gene and cell therapies, the demand for plasmid DNA manufacturing services is increasing significantly. The global Plasmid DNA Manufacturing Market is estimated to be valued at US$ 901.2 Bn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing demand for gene therapies to treat various chronic diseases like cancer, cardiovascular disease, infectious diseases, and rare genetic disorders

Stem Cells Market Stem cells have the potential to develop into many different types of cells in the body. Stem cell therapies are used to replace damaged or destroyed cells with healthy new ones. Stem cell therapies can be used to treat many degenerative diseases and conditions such as Parkinson's disease, diabetes, heart disease, and osteoarthritis. The growing prevalence of chronic diseases coupled with the increased adoption of regenerative medicines is expected to drive the global stem cell market during the forecast period. The global stem cells market is estimated to be valued at US$ 12.9 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing investments by public and private organizations in stem cell research is one of the major trends driving the growth of the global stem cells market. For instance, the University of Cambridge r

Vaccine Technologies Market Vaccine technologies are responsible for manufacturing vaccines intended to boost immunity against harmful pathogens. Vaccines contain killed or weakened versions of pathogens that aid in stimulating the immune system to produce antibodies and protect against infections. Advances in vaccine technologies including nucleic acid-based platforms like DNA and messenger RNA vaccines along with viral vector-based vaccines have enabled the development of vaccines for previously untreatable diseases at a faster pace. The global Vaccine Technologies Market is estimated to be valued at US$ 45.04 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Preventing the spread of infectious diseases presents a major market opportunity for companies involved in vaccine technologies. According to the World Health Organization, infectious diseases a